Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.82	17.67	17.01	26.21	41.64	8.99
Cash & Short-Term Investments	5.82	17.67	17.01	26.21	41.64	8.99
Cash Growth	-20.67%	3.86%	-35.09%	-37.05%	363.07%	-60.66%
Accounts Receivable	0.68	1	2.93	1.66	2.3	0.91
Other Receivables	0.2	1.63	2.29	6.82	0.47	0.45
Receivables	0.88	2.63	5.22	8.47	2.77	1.36
Prepaid Expenses	1.04	0.75	1.57	1.31	0.42	0.39
Total Current Assets	7.74	21.04	23.8	36	44.82	10.74
Property, Plant & Equipment	0.18	0.22	0.31	0.28	0.18	0.07
Long-Term Investments	0	0	0	0	0	0
Long-Term Deferred Charges	74.39	73.5	75.99	65.5	56.66	47.47
Total Assets	82.31	94.76	100.11	101.78	101.66	58.28
Accounts Payable	1.12	3.09	1.97	4.34	1.96	1.44
Accrued Expenses	2.51	2.85	3.53	2.45	4.56	2.16
Other Current Liabilities	1.46	1.91	1.29	0.4	2.91	2.65
Total Current Liabilities	5.09	7.85	6.79	7.19	9.43	6.25
Total Liabilities	5.09	7.85	6.79	7.19	9.43	6.25
Common Stock	3.06	3.06	2.69	2.69	2.69	2.08
Additional Paid-In Capital	171.39	171.39	155.19	155.19	155.19	115.27
Retained Earnings	-97.22	37.39	61.27	54.92	36.83	-65.32
Comprehensive Income & Other	-	-124.92	-125.83	-118.21	-102.47	-
Shareholders' Equity	77.23	86.91	93.32	94.59	92.23	52.03
Total Liabilities & Equity	82.31	94.76	100.11	101.78	101.66	58.28
Net Cash (Debt)	5.82	17.67	17.01	26.21	41.64	8.99
Net Cash Growth	-20.67%	3.86%	-35.09%	-37.05%	363.07%	-60.66%
Net Cash Per Share	0.24	0.81	0.79	1.19	2.04	0.54
Filing Date Shares Outstanding	21.49	24.49	21.49	21.49	21.49	18.19
Total Common Shares Outstanding	21.49	24.49	21.49	21.49	21.49	16.67
Working Capital	2.65	13.2	17.01	28.8	35.39	4.49
Book Value Per Share	3.59	3.55	4.34	4.40	4.29	3.12
Tangible Book Value	77.23	86.91	93.32	94.59	92.23	52.03
Tangible Book Value Per Share	3.59	3.55	4.34	4.40	4.29	3.12
Machinery	-	1.27	1.27	1.14	0.99	0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.